These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11679475)

  • 21. Effect of age on scramblase content in human platelets.
    Noble JM; Thomas TH; Ford GA
    Biogerontology; 2002; 3(1-2):137. PubMed ID: 12014834
    [No Abstract]   [Full Text] [Related]  

  • 22. Reconstitution of phospholipid scramblase activity from human blood platelets.
    Comfurius P; Williamson P; Smeets EF; Schlegel RA; Bevers EM; Zwaal RF
    Biochemistry; 1996 Jun; 35(24):7631-4. PubMed ID: 8672463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus.
    Wali RK; Jaffe S; Kumar D; Kalra VK
    Diabetes; 1988 Jan; 37(1):104-11. PubMed ID: 3335275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
    Wang ST; Xu JM; Wang M; Chen FL; Ding G
    Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red cell membrane lipid dynamics.
    Lubin B; Kuypers F; Chiu D
    Prog Clin Biol Res; 1989; 319():507-22; discussion 523-4. PubMed ID: 2695937
    [No Abstract]   [Full Text] [Related]  

  • 26. [Protein spectra and lipid bilayers of erythrocyte membranes in children with insulin-dependent diabetes mellitus (data from polyacrylamide gel electrophoresis and fluorescent analysis)].
    Kolosova MV; Novitskiĭ VV; Stepovaia EA; Kravets EB
    Biull Eksp Biol Med; 2000 Mar; 129(3):306-9. PubMed ID: 10776573
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH; Elhenawy YI; Nawar MM
    J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease.
    González-Clemente JM; Deulofeu R; Mitjavila J; Galdon G; Ortega E; Caixàs A; Giménez-Pérez G; Mauricio D
    Diabetes Care; 2002 Mar; 25(3):632-3. PubMed ID: 11874966
    [No Abstract]   [Full Text] [Related]  

  • 29. Electron spin resonance study of the erythrocyte membrane fluidity changes in diabetes.
    Preoteasa EA; Ionescu-Tîrgovişte C; Grecu VV; Georgescu R
    Rom J Intern Med; 1993; 31(4):271-82. PubMed ID: 8148779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.
    Colhoun HM; Taskinen MR; Otvos JD; Van Den Berg P; O'Connor J; Van Tol A
    Diabetes; 2002 Nov; 51(11):3300-5. PubMed ID: 12401722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Composition of erythrocyte membrane lipids and their biophysical parameters in children with insulin-dependent diabetes during therapy].
    Kolosova MV; Novitskiĭ VV; Stepovaia EA
    Klin Lab Diagn; 2001 Jan; (1):10-2. PubMed ID: 11233266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications.
    Zerbini G; Mangili R; Luzi L
    Diabet Med; 1999 Dec; 16(12):1048. PubMed ID: 10656236
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein composition in resting and activated platelets of type I diabetic patients.
    Maresca M; Buzzi E; Piana A; Armani U; Leoncini G
    Diabete Metab; 1989; 15(5):242-6. PubMed ID: 2630377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium-lithium countertransport in children with diabetes and their families.
    Houtman PN; Campbell FM; Shah V; Grant DB; Dunger DB; Dillon MJ
    Arch Dis Child; 1995 Feb; 72(2):133-6. PubMed ID: 7702375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red blood cell Li+/Na+ exchange in patients with diabetic nephropathy and essential hypertension: therapeutic implications.
    Semplicini A; Marzola M; Mozzato G; Ceolotto G; Pessina AC
    Ren Fail; 1993; 15(3):331-8. PubMed ID: 8516486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structural changes in erythrocyte membranes in diabetes mellitus using spin labelled fatty acids].
    Maksina AG; Mikaélian NP; Kniazev IuA; Daĭniak BA
    Biofizika; 1992; 37(2):306-9. PubMed ID: 7578322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.
    Atchley DH; Lopes-Virella MF; Zheng D; Kenny D; Virella G
    Diabetologia; 2002 Nov; 45(11):1562-71. PubMed ID: 12436340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.